You are here

BioRegion report

2022, a historic year for the BioRegion

The 2022 BioRegion of Catalonia Report, promoted by Biocat since 2009 and presented this month in front of over 600 people in Barcelona, shows a sector that is sustainably growing and beating historic records in funding for startups and scaleups, M&A operations, investors, and international capital investment, as well as offering excellent indicators in clinical trials and scientific publications.


Barcelona, February 13, 2023. In a year that looked uncertain at the start given the general drop in investment and valuations in markets worldwide, health startups and scaleups in Catalonia have once again set all-time records, securing €445 million in investment. Funding through venture capital was again the main driver of this growth, with more than €343 million in total or 77% of all capital raised.

Foreign investment also continued to hit new highs. 95% of the venture capital raised was in operations with international investors. This brought...

El Mercat del Peix forma part d'aquesta iniciativa científica, cultural i urbanística, que preveu convertir el parc de la Ciutadella i el seu entorn en una nova àrea de la ciutat centrada en el coneixement.

Catalonia gets off to a running start with new science facilities and infrastructures

2023 kicked off with a much-awaited announcement: the agreement to expand the Hospital Clinic Campus to Barcelona’s Diagonal area and create a great hub of knowledge in health. In addition to this project, many other new strategic initiatives, facilities and infrastructures kicked off in 2022 to bolster Catalonia’s strategic international positioning in health research, technology and innovation.


AXA Auditorium, Barcelona

Panoràmica ciutat de Barcelona

2021, an exceptional year for the BioRegion

The 2021 BioRegion Report, promoted by Biocat with CataloniaBio & HealthTech and ACCIÓ, shows the sector’s evolution in a year marked by efforts in health innovation, and with European and global challenges in its sights. 

Aortyx guanya Premis Àlex Casta

Ona Therapeutics, Glycardial, ABLE Human Motion and Pebble Analytics were the other finalists in this event that took place during the presentation of the 2020 BioRegion Report

Jordi Naval i Judit Anido

Venture capital with international participation is up 67.1%, becoming the main driving force behind increased investment, according to BioRegion of Catalonia Life Sciences and Healthcare Outlook 2020 - Challenges Ahead, presented by Biocat and CataloniaBio & HealthTech.